Results 31 to 40 of about 49,264 (163)

sj-docx-1-aan-10.1177_02184923211042136 - Supplemental material for Atrial fibrillation management during septal myectomy for hypertrophic cardiomyopathy: A systematic review

, 2021
Supplemental material, sj-docx-1-aan-10.1177_02184923211042136 for Atrial fibrillation management during septal myectomy for hypertrophic cardiomyopathy: A systematic review by Michael Seco, Jonathan CL Lau, Caroline Medi and Paul G Bannon in Asian ...
Michael Seco (11400942), Jonathan CL Lau (11400945), Paul G Bannon (11400951), Caroline Medi (11400948)   +3 more
core   +1 more source

Modified Morroq Septal Myectomy Associated with a Transaortic Mitral Edge-to-Edge Suture for an Obstructive HCM

, 2022
This video describes a surgical technique to treat severe symptomatic obstructive hypertrophic cardiomyopathy (HCM) through a median sternotomy. This technique is mainly inspired from the morrow septal myectomy.
Jean Francois Obadia (9242047), Danial Grinberg (12317015)   +1 more
core   +1 more source

Impact of sex on timing and clinical outcome of septal myectomy for obstructive hypertrophic cardiomyopathy [PDF]

, 2021
Background: Sex disparities are common in hypertrophic cardiomyopathy (HCM). Previous research has shown that at time of myectomy, women are older, have greater impairment of diastolic function and more advanced cardiac remodeling. The clinical impact of
Hirsch, Alexander, de Jong, P.L., van Slegtenhorst, Marjon, Schinkel, Arend F. L., de Jong, Peter L., Michels, Michelle; id_orcid, Hirsch, Alexander; id_orcid, van Slegtenhorst, Marjon A., Huurman, Roy, Schinkel, Arend, Michels, Michelle   +10 more
core   +2 more sources

Left Ventricular Enlargement Procedure in a Patient with Diffuse-Type Hypertrophic Cardiomyopathy: A Case Report

Journal of Chest Surgery, 2022
Surgical septal myectomy is the preferred treatment option for patients with medically intractable obstructive hypertrophic cardiomyopathy. Extended transaortic septal myectomy is a widely performed surgical procedure for patients with subaortic ...
Dong Youb Han, Sung Jun Park, Sung-Ho Jung   +2 more
doaj   +1 more source

Transaortic Septal Myectomy

, 2019
This educational video explains the crucial operative steps in completing a transaortic septal myectomy for the treatment of hypertrophic obstructive cardiomyopathy.
Pietro Bajona (6420551), Ryan J. Vela (6551866)   +1 more
core   +1 more source

Use of the novel virtual myectomy in guiding thoracoscopic myectomy for patients with hypertrophic obstructive cardiomyopathy

International Journal of Cardiology: Heart & Vasculature
Background: This study aimed to evaluate the efficacy of a novel virtual myectomy procedure in guiding thoracoscopic trans-mitral myectomy. Methods and Results: Clinical data from 37 patients who underwent thoracoscopic trans-mitral septal myectomy ...
Peijian Wei, Tong Tan, Shengwen Wang, Jiexu Ma, Guanyu Lu, Haozhong Liu, Hanxiang Xie, Wei Zhu, Jian Zhuang, Jian Liu, Huiming Guo   +10 more
doaj   +1 more source

Sutureless Aortic Valve Replacement in a Patient with Transfemoral Aortic Valve Replacement and Left Ventricular Hypertrophy

The Thoracic & Cardiovascular Surgeon Reports, 2015
Background Transarterial valve intervention (TAVI) is valuable in high-risk patients, however, in case of left ventricular outflow tract (LVOT) obstruction, conventional surgery, including partial myectomy, is indicated.
Torsten Christ, Pascal M. Dohmen, Michael Laule, Karl Stangl, Wolfgang Konertz   +4 more
doaj   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Transcatheter aortic valve replacement for aortic regurgitation after septal myectomy in patients with obstructive hypertrophic cardiomyopathy

, 2020
Transaortic septal myectomy is currently considered to be the most appropriate surgical treatment for patients with obstructive hypertrophic cardiomyopathy (HCM) and heart failure symptoms unresponsive to medical therapy (1).
Russo D., Castriota F., Autore C., Nerla R., Arcari L., Limite L. R., Casenghi M., Musumeci M. B.   +7 more
core   +1 more source

Minimally Invasive Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy

, 2017
Surgical septal myectomy is the treatment of choice for patients with symptomatic hypertrophic obstructive cardiomyopathy refractory to medications.
Ralph J. Damiano, Farah N. Musharbash, Matthew C. Henn, Matthew R. Schill   +3 more
core   +1 more source